Nijmegen – 28 March 2023: Avivia B.V. proudly announces the appointment of Lee Ayres as its new Managing Director, effective immediately. Lee brings with him over 20 years of experience in business leadership within the medical field. His appointment marks a significant milestone in Avivia’s journey toward becoming a prominent player in Europe’s pharmaceutical formulation development and analytical services.
Before assuming his role at Avivia, Lee served as the Chief Technology Officer and co-founder of Encapson, a company specializing in echogenic coating for medical devices, where he led the development of the Sono-Coat® technology. Alongside being a member of the Management Team, as CTO he led the business development, sales and marketing activities. The Sono-Coat Technology was acquired by LipoCoat in 2024.
Menno Wiltink, Scientific Director, expressed his enthusiasm regarding Lee’s appointment “We are delighted to welcome Lee as our new Managing Director. Lee is a dynamic, enthusiastic, driven business leader with a diverse background of experiences and an excellent track record.”
Dennie van den Heuvel, Development Director, echoed this sentiment “He has strong strategic capabilities, proven operational effectiveness and strong customer service experience. The shareholders look forward to Lee realizing Avivia’s full potential as a service-oriented company.”
Lee conveyed his excitement at joining the Avivia team “I am delighted to have been appointed Managing Director of Avivia. Their expertise in the fields of formulation development and excipient analysis is second to none. Their commitment to providing creative solutions for our customers problems is impressive. I’m incredibly excited to join the team and look forward to working with them in delivering long term growth in the coming years.”
